The Glioblastoma Research Organization launches The Lee Project: Using Evolution To Target GBM at The University of Texas MD Anderson Cancer Center
HOUSTON, Aug. 11, 2020 /PRNewswire-PRWeb/ --Funded by the Glioblastoma Research Organization, the Laboratory of Dr. Steven Millward at MD Anderson Cancer Center has launched the The Lee Project which focuses on directed evolution of vectors for the treatment of GBM.
- HOUSTON, Aug. 11, 2020 /PRNewswire-PRWeb/ --Funded by the Glioblastoma Research Organization, the Laboratory of Dr. Steven Millward at MD Anderson Cancer Center has launched the The Lee Project which focuses on directed evolution of vectors for the treatment of GBM.
- Glioblastoma remains one of the most lethal cancers, due in large part to its invasiveness and dissemination throughout normal brain tissue.
- As a result, surgical resection and targeted radiotherapy are extremely challenging in GBM patients.
- While advances in chemotherapy have dramatically improved patient outcomes in non-CNS tumors, GBM remains refractory to most chemotherapeutics.